-+ 0.00%
-+ 0.00%
-+ 0.00%

Iovance Biotherapeutics Affirms FY2026 Sales Guidance of $410.000M-$420.000M vs $416.263M Est

Benzinga·11/05/2026 12:10:41
Listen to the news
Iovance Biotherapeutics (NASDAQ:IOVA) affirms FY2026 sales outlook from $410.000 million-$420.000 million to $410.000 million-$420.000 million vs $416.263 million estimate.